UNSPSC 85603823: Supplement rectum with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement rectum with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUP47Z

UNSPSC 85603823 Supplement rectum with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not reflect the actual scope of recent state and local contracting activity tagged under it. The recent opportunities posted under this code involve procurement of medical services, pharmacy benefit management, virtual care platforms, peer support programs, and emergency medical direction — none of which align with surgical procedure codes for tissue augmentation. The mismatch suggests either a cataloging error in the issuing bodies' procurement systems or an unrelated application of the code to healthcare contract opportunities.

The recent opportunities span multiple jurisdictions and issuing bodies across Florida and Georgia, including Columbus Consolidated Government (Muscogee County Prison medical and pharmacy services, RFP 26-0008, due May 15, 2026), Collier County Board of County Commissioners (pharmacy benefit management services, RFP 25-8414, due April 9, 2026), Monroe County Board of County Commissioners (virtual primary and urgent care services, RFP, due April 16, 2026), San Mateo County Health (peer support pilot project for peer workers, RFP 2025-007), and Santa Monica Fire Department (EMS medical director services, RFP 455). Given the systematic misalignment between the code's procedural classification and the healthcare administration, staffing, and management services actually being solicited, this code shows little relevant recent activity for vendors pursuing clinical procedure contracting or tissue-substitute supply lines.